摘要 :[目标]分析心肌梗死(MI)患者住院诊疗情况。[方法]2021年1月至2021年5月心肌梗死患者,对诊疗情况进行调查分析。[结果]%的AMI患者行急诊PCI,阿司匹林、***吡格雷、低分子肝素、ACEI/ARB、她汀类药品、中药的使用情况很好,β受体阻滞剂的使用率偏低。[结论]MI诊疗基础上遵照了国际上公认的指南,但β受体阻滞剂使用仍有提升的空间,中药得到了广泛的应用,但其疗效缺乏大量的循证医学证据。 关键词 心肌梗死; 再灌注; 诊疗情况 Abstract:[Objective] To analyse the therapies of the hospitalized patients with myocardial infarction. [Methods] To select the hospitalized patients with myocardial infarction between January 2021 and May 2021 and to investigate the patients, therapies. [Results] % of the AMI patients received therapy of emergency PCI and the utilization rates of aspirin, clopidogrel, lowmolecularweight heparin, ACEI/ ARB, statins; Chinese medicine was better but the utilization rate of betablocker was slightly lower. [Conclusions]The guidelines were implemented in the therapies of myocardial infarction patients, but the use of betablocker still could be improved, Chinese medicine was widely used, but still needed to be proved by evidencebased medicine. Key words: myocardial infarction; reperfusion; current status of therapies 心肌梗死是在冠脉严重病变的基础上,因为血管内斑块的糜烂和破裂并发血栓形成,血管痉挛等原因使冠脉血供急剧降低或中止所致的急性心肌缺血坏死,是冠心病严重类型,也是心血管病的主要致死原因之一,属中医的“胸痹心痛”、“真心痛”、“厥心痛”等范围。本文意在调查统计分析在我院住院诊疗的心肌梗死患者的诊疗情况,了解对指南的遵照情况。 1 调查对象及方法 调查对象 参考2021年ESC/ACCF/AHA/WHF(European Society of Cardiology/ American College of Cardiology Foundation/ American Heart Asso